In addition to the low frequency, non-synonymous variant in the PLCG2 gene (rs72824905, MAF: 0.6%), which was recently observed to be protective against AD, frontotemporal dementia (FTD) and dementia with Lewy bodies, other variants within this group were previously linked with disease risk factors. This evidence concerns the gene PLCG2 and Alzheimer disease.